These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37282794)

  • 1. Longitudinal latent polysubstance use patterns among a cohort of people who use opioids in Vancouver, Canada.
    Karamouzian M; Cui Z; Hayashi K; DeBeck K; Milloy MJ; Buxton JA; Kerr T
    Drug Alcohol Rev; 2023 Sep; 42(6):1493-1503. PubMed ID: 37282794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal polysubstance use patterns and non-fatal overdose: A repeated measures latent class analysis.
    Karamouzian M; Cui Z; Hayashi K; DeBeck K; Reddon H; Buxton JA; Kerr T
    Int J Drug Policy; 2024 Jan; ():104301. PubMed ID: 38182524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent patterns of polysubstance use among people who use opioids: A systematic review.
    Karamouzian M; Pilarinos A; Hayashi K; Buxton JA; Kerr T
    Int J Drug Policy; 2022 Apr; 102():103584. PubMed ID: 35074608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.
    Karamouzian M; Buxton JA; Hategeka C; Nosova E; Hayashi K; Milloy MJ; Kerr T
    Int J Drug Policy; 2022 Nov; 109():103852. PubMed ID: 36122483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
    Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K
    Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197
    [No Abstract]   [Full Text] [Related]  

  • 6. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.
    Timko C; Han X; Woodhead E; Shelley A; Cucciare MA
    J Stud Alcohol Drugs; 2018 Sep; 79(5):799-807. PubMed ID: 30422794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance.
    Stevens AK; Gunn RL; Sokolovsky AW; Colby SM; Jackson KM
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):701-713. PubMed ID: 33970653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysubstance use and re-incarceration in the 12-months after release from jail: a latent transition analysis of rural Appalachian women.
    Bunting AM; Dickson M; Staton M
    Am J Drug Alcohol Abuse; 2022 May; 48(3):356-366. PubMed ID: 35130103
    [No Abstract]   [Full Text] [Related]  

  • 10. A Latent Class Analysis of Substance Use and Longitudinal HIV RNA Patterns Among PWH in DC Cohort.
    Byrne M; Monroe AK; Doshi RK; Horberg MA; Castel AD;
    AIDS Behav; 2024 Feb; 28(2):682-694. PubMed ID: 38319460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially classified methamphetamine-using men who have sex with men: A latent class analysis.
    Wilkerson JM; Noor SW; Rhoton JM; Li D; Rosser BRS
    Drug Alcohol Depend; 2018 Nov; 192():129-136. PubMed ID: 30248559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal methamphetamine use subgroups and associated addiction care access and overdose risk in a Canadian urban setting.
    Brooks O; Bach P; Dong H; Milloy MJ; Fairbairn N; Kerr T; Hayashi K
    Drug Alcohol Depend; 2022 Mar; 232():109274. PubMed ID: 35033951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of polysubstance use and simultaneous co-use in high risk young adults.
    Bailey AJ; Farmer EJ; Finn PR
    Drug Alcohol Depend; 2019 Dec; 205():107656. PubMed ID: 31706247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysubstance use latent class membership in New Jersey: Association with prior overdoses, prior emergency department peer recovery engagement, and mental health diagnosis among participants in an opioid overdose recovery program.
    Lardier DT; Gilmore Powell K; Peterson NA; Borys S; Hallcom DK
    Subst Abus; 2022; 43(1):1011-1022. PubMed ID: 35435801
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential risks of syringe service program participants in Central Ohio: a latent class analysis.
    Moon KJ; Bryant I; Trinh A; Hasenstab KA; Carter B; Barclay R; Nawaz S
    Harm Reduct J; 2023 Jul; 20(1):97. PubMed ID: 37507721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health.
    Bobashev GV; Warren LK
    Drug Alcohol Depend; 2022 Sep; 238():109553. PubMed ID: 35905594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Circumstances Surrounding Overdose and Underlying Classes of Polysubstance Overdose Deaths.
    Thomas SA; Wagner KD; Clements-Nolle KD; Omaye S; Lu M; Yang W
    Subst Use Misuse; 2023; 58(3):434-443. PubMed ID: 36617896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
    Gjersing L; Bretteville-Jensen AL
    Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the dynamic transitions of polysubstance use patterns among Canadian youth using Latent Markov Models on COMPASS data.
    Yang Y; Butt ZA; Leatherdale ST; Morita PP; Wong A; Rosella L; Chen HH
    Lancet Reg Health Am; 2022 Dec; 16():100389. PubMed ID: 36777157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.
    Reddon H; Lake S; Socias ME; Hayashi K; DeBeck K; Walsh Z; Milloy MJ
    Int J Drug Policy; 2023 Sep; 119():104113. PubMed ID: 37481875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.